SCHEMBL3851249

SCHEMBL3851249

CC1(C)OCC(C(Br)Br)O1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10485459 0.84 CA2 (0.31) CA2
SCHEMBL13381150 0.78 CA2 (0.32) CA2
SCHEMBL12230294 0.78 CA2 (0.32) CA2
SCHEMBL21574813 0.78 CA2 (0.32) CA2
SCHEMBL14044273 0.78 CA2 (0.32) CA2
SCHEMBL10314711 0.78 CA2 (0.32) CA2
SCHEMBL17616015 0.78 CA2 (0.32) CA2
SCHEMBL10314717 0.78 CA2 (0.32) CA2
SCHEMBL10981965 0.76 CA2 (0.32) CA2
SCHEMBL20788826 0.76 CA2 (0.32) CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2050747-A1 Dimers of harmol or of its derivatives and uses thereof BioAlliance Pharma (FR) 2009-04-22 — — EP claimed
WO-2009047298-A2 DIMERS OF HARMOL OR OF ITS DERIVATIVES AND USES THEREOF BIOALLIANCE PHARMA (FR) 2009-04-16 — — WO claimed
EP-2050747-A1 Dimers of harmol or of its derivatives and uses thereof BioAlliance Pharma (FR) 2009-04-22 — — EP disclosed
WO-2009047298-A2 DIMERS OF HARMOL OR OF ITS DERIVATIVES AND USES THEREOF BIOALLIANCE PHARMA (FR) 2009-04-16 — — WO disclosed
Send feedback